The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial

EuroIntervention 2011;7:936-943 publish online ahead of print August 2011. DOI: 10.4244/EIJV7I8A148

1. Gil Hospital, Gachon University of Medicine and Science, Incheon, Republic of Korea; 2. Chonnam National University Hospital, Gwangju, Republic of Korea; 3. Wonju Christian Hospital, Wonju, Republic of Korea; 4. Yeungnam University H

Aims: The aim of this study was to compare the efficacy and safety of zotarolimus-eluting stents (ZES), sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES)

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

The physiological significance of coronary aneurysms in Kawasaki disease